PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.\', \'Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York.\', \'Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York.\', \'Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.\', \'Texas Biomedical Research Institute, San Antonio, Texas.\', \'Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/cpmc.108
?:doi
?:hasPublicationType
?:journal
  • Current protocols in microbiology
is ?:pmid of
?:pmid
?:pmid
  • 32585083
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.759
?:rankingScore_hIndex
  • 23
?:title
  • An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32585083>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32585083>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all